Streetbeat News

Revenues

BYDDF

BYD Co is exploring the possibility of establishing a manufacturing plant in Mexico, as stated by the head of the company's local unit. This initiative is part of BYD's broader strategy in Latin America, which includes a plan to invest 3 billion Reals in constructing a plant in Brazil. The company has initiated a feasibility study for the Mexican plant to assess the potential and logistics of the expansion.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 5:39 pm

BTCUSD

DIA

QQQ

SPY

Bitcoin and gold prices fell following a hotter-than-expected US inflation report, with BTC dropping over 2% and gold sliding below $2k for the first time in 2024. The S&P 500, Dow Jones, and Nasdaq also experienced declines. Analysts suggest that the CPI data, showing a 3.1% increase over the past year, could lead to further dips in Bitcoin if negative market sentiment continues.

Portfolio Pulse from Benzinga Contributor

February 13, 2024 | 5:36 pm

AMD

AVGO

CRDO

INTC

NVDA

SOXX

Mizuho Securities has increased its price targets for Nvidia, AMD, Broadcom, and Credo Technology, citing the booming AI market expected to reach $400 billion by 2027. Nvidia, AMD, Broadcom, and Intel are projected to be major beneficiaries of this growth, with significant increases in their AI revenue forecasts. The analyst highlights strong demand for AI chips, tight supplies of Nvidia's H100 AI accelerator chipset, and anticipates further acceleration in demand in 2024. Nvidia's upcoming B100 launch is also seen positively for its 2024 guidance.

Portfolio Pulse from Shanthi Rexaline

February 13, 2024 | 5:25 pm

HWM

Howmet Aerospace Inc (NYSE:HWM) shares rose after reporting strong Q4 FY23 results, with a 14% Y/Y revenue increase to $1.73 billion, surpassing the $1.65 billion consensus. Adjusted EPS grew 39% Y/Y to $0.53, beating the $0.47 consensus. The company also highlighted a positive outlook for FY24, expecting revenue between $7.00 billion and $7.20 billion and adjusted EPS of $2.10-$2.20. Howmet's optimistic outlook is supported by strong commercial aerospace demand and record backlogs at aircraft OEMs.

Portfolio Pulse from Lekha Gupta

February 13, 2024 | 5:16 pm

HWC

Hancock Whitney (NASDAQ:HWC) has received mixed analyst ratings over the past three months, with an updated average 12-month price target of $52.38, reflecting a 9.13% increase from the previous target of $48.00. Analysts' actions vary from maintaining to raising and lowering their stances, indicating diverse perspectives on the company's performance and market position. Despite facing a -13.17% decline in revenue growth and below-average financial health indicators, such as ROE and ROA, the company's market capitalization and debt management are noted. The detailed analysis of analyst ratings and financial health suggests a nuanced view of Hancock Whitney's current state and future prospects.

Portfolio Pulse from Benzinga Insights

February 13, 2024 | 5:00 pm

HAL

Analyst ratings for Halliburton (NYSE:HAL) show a mix of bullish and somewhat bullish sentiments, with recent adjustments lowering price targets. The average 12-month price target is now $48.8, down from $51.67. Halliburton's financial performance is strong, with notable revenue growth, high net margin, and effective debt management. The company is a leading oilfield service firm with significant market capitalization and innovation in hydraulic fracturing.

Portfolio Pulse from Benzinga Insights

February 13, 2024 | 5:00 pm

BIIB

Eight analysts have recently shared their views on Biogen (NASDAQ:BIIB), with opinions ranging from bullish to bearish. The average 12-month price target for BIIB has been adjusted to $291.0, down from $302.00, reflecting a 3.64% decline. Analyst actions include maintaining, raising, and lowering ratings and price targets, indicating varied perceptions of Biogen's market position. Biogen's financial performance shows strong net margin and ROE, but its revenue growth and market capitalization are below industry averages.

Portfolio Pulse from Benzinga Insights

February 13, 2024 | 5:00 pm

PTVE

In the last three months, 5 analysts have updated their ratings on Pactiv Evergreen (NASDAQ:PTVE), with a shift towards a more neutral stance in the last 30 days. The average 12-month price target for PTVE has been raised to $16.3, indicating a 39.67% increase from the previous target of $11.67. Analysts from Goldman Sachs, Jefferies, UBS, Citigroup, and B of A Securities have adjusted their ratings and price targets, reflecting changes in market dynamics and company performance. Despite facing revenue challenges with a -14.29% growth over 3 months, PTVE shows strong financial health with a net margin of 2.1%, an ROE of 2.25%, and an ROA of 0.44%, outperforming industry benchmarks.

Portfolio Pulse from Benzinga Insights

February 13, 2024 | 5:00 pm

POL

Polished.com has revised its fiscal year 2023 revenue guidance downwards from the previously estimated range of $330M-$350M to $315M-$325M, and now expects EBITDA to be below its earlier forecast. The adjustment is attributed to ongoing macroeconomic challenges affecting consumer discretionary spending. The company highlights that these projections, made as of February 12, 2024, are subject to significant uncertainties including economic conditions, inflation, interest rates, and supply chain constraints.

Portfolio Pulse from Benzinga Newsdesk

February 13, 2024 | 4:52 pm

ECL

Ecolab Inc (NYSE:ECL) shares surged after reporting Q4 FY23 results that exceeded expectations and providing optimistic Q1 FY24 EPS guidance. Sales increased by 7% Y/Y to $3.938 billion, slightly above analyst estimates. Adjusted operating income rose 24% Y/Y, and the company expects a strong FY24 with adjusted EPS guidance of $6.10-$6.50, against an estimate of $6.14. Ecolab's CEO expressed confidence in continued earnings growth and margin expansion.

Portfolio Pulse from Lekha Gupta

February 13, 2024 | 4:43 pm